Helicobacter pylori 1988-1998

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 1, 1999, Pages 13-16

  McColl, Kenneth E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH CITRATE; CIMETIDINE; NONSTEROID ANTIINFLAMMATORY AGENT; TINIDAZOLE;

BACTERIUM CULTURE; DUODENUM ULCER; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LOWER ESOPHAGUS SPHINCTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHORT SURVEY; STOMACH CARCINOMA; STOMACH ULCER;

EID: 0033019994     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199901000-00003     Document Type: Short Survey

References (44)

1. Coghlan JG, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, Keane C, O'Morain C. Campylobacter pylori and recurrence of duodenal ulcers - a 12 month follow-up study. Lancet 1987; ii:1109-1111.
2. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; ii:1437-1441.
3. Peterson WL. Antimicrobial therapy of duodenal ulcer? Hold off for now! Gastroenterology 1989; 97:508-510.
4. Penston JG. Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharmacol Ther 1996; 10:469-486.
5. McColl KEL, El-Omar E, Gillen D. Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. Br Med Bull 1998; 54:121-138.
6. El-Omar E, Penman ID, Ardill JES, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109:681-691.
7. Olbe L, Hamlet A, Dalenback J, Fandriks L. A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology 1996; 110:1386-1394.
8. Axon ATR, O'Morain CA, Bardhan KD, Crowe JP, Beattie AD, Thompson RPH, et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. BMJ 1997; 314:565-568.
9. Sung JY, Chung SC, Ling TKW, Yung MY, Leung VKS, Ng EKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylon. N Engl J Med 1995; 332:139-142.
10. Bayerdörffer E, Miehlke S, Lehn N, Mannes GA, Höchter W, Weingart J, et al. Cure of gastric ulcer disease after cure of Helicobacter pylori infection - German gastric ulcer study. Eur J Gastroenterol Hepatol 1996; 8:343-349.
11. Labenz J. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55:19-23.
12. Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastroint Endosc 1995; 41:5-7.
13. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastroint Endosc 1995; 41:1-4.
14. Roseveare CD, Colin-Jones DG. Helicobacter pylori and non-steroidal anti-inflammatory drugs: lone agents or partners in crime? Eur J Gastroenterol Hepatol 1997; 9:935-937.
15. Gilvarry J, Buckley MJM, Beattie S, Hamilton H, O'Morain CA. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 1997; 32:535-540.
16. Laheij RJF, Janasen JBMJ, Van de Lisdonk EH, Severens JL, Verbeek ALM. Review article: symptom improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 1996; 10:843-850.
17. Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991 ; 302:1302-1305.
18. Nomura A, Stemmermann GN, Po-Huang C, Kato I, Perez-Perez Gl, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325:1132-1136.
19. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-1131.
20. Parsonnet J, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, et al. Helicobacter pylori and gastric lymphoma. N Engl J Med 1994; 330:1267-1271.
21. Montalban C, Manzanai A, Boixeda D, Redondo C, Bellas C. Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Lancet 1995; 345:798-799.
22. Blecker U, McKeithan TW, Hart J, Kirschner S. Resolution of Helicobacter pylori-associated gastric lymphoproliferative disease in a child. Gastroenterology 1995; 109:973-977.
23. Zucca E, Roggero E, Pileri S. Review: B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumours. Br J Haematol 1998; 100:3-14.
24. Working Group, Lyon, France. Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 61: Schistosomes, Liver Flukes and Helicobacter pylori. International Agency for Research on Cancer; 1994. pp. 177-240.
25. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90:5791-5795.
26. Blaser MJ, Perez-Perez Gl, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-2115.
27. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991; 338:332-335.
28. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40:297-301.
29. Blaser MJ, Crabtree JE. CagA and the outcome of Helicobacter pylori infection. Am J Clin Pathol 1996; 106:565-567.
30. Hansen S, Vollset SE, Melby K, Aase S, Jellun E, Fyfe V, Ferguson KEL. Gastric mucosal atrophy is a strong predictor of non-cardia gastric cancer but not of cardia cancer [abstract]. Gastroenterology 1998; 114(4Part2):A606.
31. Hansson L-E, Sparén P, Nyrén O. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg 1993; 80:374-377.
32. Blot W, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 13:1287-1289.
33. Patel P, Mendall MA, Khulusi S, Molineaux N, Levy J, Maxwell JD, Northfield TC. Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet 1994; 344:511-512.
34. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996; 110:72-83.
35. McColl KEL, El-Nujumi A, Murray L, El-Omar E, Gillen D, Dickson A, et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997; 40:302-306.
36. Axon ATR. Campylobacter pylori - therapy review. Scand J Gastroenterol 1989; 24 (suppl 160):35-38.
37. Chiba N, Rao BV, Rademaker JW, Hunt R. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 87:1716-1727.
38. Bell GD, Powell KU, Burridge SM, Bowden AN, Rameh B, Bolton G, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med 1993; 86:743-750.
39. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8:359-368.
40. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 308-312.
41. de Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol 1995; 7:1189-1194.
42. Mendall MA, Northfield TC. Transmission of Helicobacter pylori infection. Gut 1995; 37:1-3.
43. Czinn SJ. What is the role for vaccination in Helicobacter pylori? Gastroenterology 1997; 113(suppl 6):S149-S153.
44. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997; 388:539-547.